Clinical Trial Detail

NCT ID NCT03840967
Title A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Shadia Jalal, MD
Indications

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma

gastric adenocarcinoma

Therapies

Niraparib

Age Groups: adult senior

Additional content available in CKB BOOST